Number of items: 3.
2026
Wei, L. et al.
(2026)
A Type 2 Diabetes Policy Model that predicts remaining life expectancy, quality adjusted life expectancy and healthcare costs for use in economic evaluation, incorporating equity concerns.
Diabetes, Obesity and Metabolism,
(doi: 10.1111/dom.70657)
(Early Online Publication)
2020
McMeekin, P., Geue, C.
ORCID: https://orcid.org/0000-0003-2243-0733, Mocevic, E., Hoxer, C.S., Ochs, A., McGurnaghan, S., Colhoun, H.M., Wild, S.H. and Wu, O.
ORCID: https://orcid.org/0000-0002-0570-6016
(2020)
The cost of prevalent and incident cardiovascular disease in people with type 2 diabetes in Scotland: Data from the Scottish Care Information - Diabetes Collaboration (SCI-Diabetes).
Diabetic Medicine, 37(11),
pp. 1927-1934.
(doi: 10.1111/dme.14253)
(PMID:31989661)
Cadilhac, D. A. et al.
(2020)
Improving economic evaluations in stroke: a report from the ESO Health Economics Working Group.
European Stroke Journal, 5(2),
pp. 184-192.
(doi: 10.1177/2396987319897466)
(PMID:32637652)
(PMCID:PMC7313366)
This list was generated on Fri Mar 20 15:27:16 2026 GMT.